Literature DB >> 23686817

Deletions of 16p11.2 and 19p13.2 in a family with intellectual disability and generalized epilepsy.

Alexander G Bassuk1, Eileen Geraghty, Shu Wu, Saul A Mullen, Samuel F Berkovic, Ingrid E Scheffer, Heather C Mefford.   

Abstract

Rare copy number variants (CNVs) have been established as an important cause of various neurodevelopmental disorders, including intellectual disability (ID) and epilepsy. In some cases, a second CNV may contribute to a more severe clinical presentation. Here we present two siblings and their mother who have mild ID, short stature, obesity and seizures. Array CGH studies show that each affected individual has two large, rare CNVs. The first is a deletion of chromosome 16p11.2, which has been previously associated with ID and autism. The second is a 0.9 Mb deletion of 19p13.2, which results in the deletion of a cluster of zinc finger genes. We suggest that, while the 16p11.2 deletion is likely the primary cause of the obesity and ID in this family, the 19p13.2 deletion may act as a modifier of the epilepsy phenotype, which is not a core feature of the 16p11.2 deletion syndrome. We investigate the potential role of ZNF44, a gene within the deleted region, in a cohort of patients with generalized epilepsy.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686817      PMCID: PMC4169108          DOI: 10.1002/ajmg.a.35946

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

Review 1.  Casein kinase 2 as a potentially important enzyme in the nervous system.

Authors:  P R Blanquet
Journal:  Prog Neurobiol       Date:  2000-02       Impact factor: 11.685

2.  Array-CGH detection of a de novo 0.7-Mb deletion in 19p13.13 including CACNA1A associated with mental retardation and epilepsy with infantile spasms.

Authors:  Stéphane Auvin; Muriel Holder-Espinasse; Marie-Dominique Lamblin; Joris Andrieux
Journal:  Epilepsia       Date:  2009-11       Impact factor: 5.864

3.  Rare copy number variants are an important cause of epileptic encephalopathies.

Authors:  Heather C Mefford; Simone C Yendle; Cynthia Hsu; Joseph Cook; Eileen Geraghty; Jacinta M McMahon; Orvar Eeg-Olofsson; Lynette G Sadleir; Deepak Gill; Bruria Ben-Zeev; Tally Lerman-Sagie; Mark Mackay; Jeremy L Freeman; Eva Andermann; James T Pelakanos; Ian Andrews; Geoffrey Wallace; Evan E Eichler; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

Review 4.  Phenotypic variability and genetic susceptibility to genomic disorders.

Authors:  Santhosh Girirajan; Evan E Eichler
Journal:  Hum Mol Genet       Date:  2010-08-31       Impact factor: 6.150

5.  Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.

Authors:  Heather C Mefford; Hiltrud Muhle; Philipp Ostertag; Sarah von Spiczak; Karen Buysse; Carl Baker; Andre Franke; Alain Malafosse; Pierre Genton; Pierre Thomas; Christina A Gurnett; Stefan Schreiber; Alexander G Bassuk; Michel Guipponi; Ulrich Stephani; Ingo Helbig; Evan E Eichler
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

6.  A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.

Authors:  R G Walters; S Jacquemont; A Valsesia; A J de Smith; D Martinet; J Andersson; M Falchi; F Chen; J Andrieux; S Lobbens; B Delobel; F Stutzmann; J S El-Sayed Moustafa; J-C Chèvre; C Lecoeur; V Vatin; S Bouquillon; J L Buxton; O Boute; M Holder-Espinasse; J-M Cuisset; M-P Lemaitre; A-E Ambresin; A Brioschi; M Gaillard; V Giusti; F Fellmann; A Ferrarini; N Hadjikhani; D Campion; A Guilmatre; A Goldenberg; N Calmels; J-L Mandel; C Le Caignec; A David; B Isidor; M-P Cordier; S Dupuis-Girod; A Labalme; D Sanlaville; M Béri-Dexheimer; P Jonveaux; B Leheup; K Ounap; E G Bochukova; E Henning; J Keogh; R J Ellis; K D Macdermot; M M van Haelst; C Vincent-Delorme; G Plessis; R Touraine; A Philippe; V Malan; M Mathieu-Dramard; J Chiesa; B Blaumeiser; R F Kooy; R Caiazzo; M Pigeyre; B Balkau; R Sladek; S Bergmann; V Mooser; D Waterworth; A Reymond; P Vollenweider; G Waeber; A Kurg; P Palta; T Esko; A Metspalu; M Nelis; P Elliott; A-L Hartikainen; M I McCarthy; L Peltonen; L Carlsson; P Jacobson; L Sjöström; N Huang; M E Hurles; S O'Rahilly; I S Farooqi; K Männik; M-R Jarvelin; F Pattou; D Meyre; A J Walley; L J M Coin; A I F Blakemore; P Froguel; J S Beckmann
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

7.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.

Authors:  Carolien G F de Kovel; Holger Trucks; Ingo Helbig; Heather C Mefford; Carl Baker; Costin Leu; Christian Kluck; Hiltrud Muhle; Sarah von Spiczak; Philipp Ostertag; Tanja Obermeier; Ailing A Kleefuss-Lie; Kerstin Hallmann; Michael Steffens; Verena Gaus; Karl M Klein; Hajo M Hamer; Felix Rosenow; Eva H Brilstra; Dorothée Kasteleijn-Nolst Trenité; Marielle E M Swinkels; Yvonne G Weber; Iris Unterberger; Fritz Zimprich; Lydia Urak; Martha Feucht; Karoline Fuchs; Rikke S Møller; Helle Hjalgrim; Peter De Jonghe; Arvid Suls; Ina-Maria Rückert; Heinz-Erich Wichmann; Andre Franke; Stefan Schreiber; Peter Nürnberg; Christian E Elger; Holger Lerche; Ulrich Stephani; Bobby P C Koeleman; Dick Lindhout; Evan E Eichler; Thomas Sander
Journal:  Brain       Date:  2009-10-20       Impact factor: 13.501

8.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

9.  Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

Authors:  Santhosh Girirajan; Jill A Rosenfeld; Bradley P Coe; Sumit Parikh; Neil Friedman; Amy Goldstein; Robyn A Filipink; Juliann S McConnell; Brad Angle; Wendy S Meschino; Marjan M Nezarati; Alexander Asamoah; Kelly E Jackson; Gordon C Gowans; Judith A Martin; Erin P Carmany; David W Stockton; Rhonda E Schnur; Lynette S Penney; Donna M Martin; Salmo Raskin; Kathleen Leppig; Heidi Thiese; Rosemarie Smith; Erika Aberg; Dmitriy M Niyazov; Luis F Escobar; Dima El-Khechen; Kisha D Johnson; Robert R Lebel; Kiana Siefkas; Susie Ball; Natasha Shur; Marianne McGuire; Campbell K Brasington; J Edward Spence; Laura S Martin; Carol Clericuzio; Blake C Ballif; Lisa G Shaffer; Evan E Eichler
Journal:  N Engl J Med       Date:  2012-09-12       Impact factor: 91.245

10.  Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications.

Authors:  Jill A Rosenfeld; Justine Coppinger; Bassem A Bejjani; Santhosh Girirajan; Evan E Eichler; Lisa G Shaffer; Blake C Ballif
Journal:  J Neurodev Disord       Date:  2010-03       Impact factor: 4.025

View more
  9 in total

1.  DNA Damage Analysis in Children with Non-syndromic Developmental Delay by Comet Assay.

Authors:  Surraj Susai; Parkash Chand; Vishnu Bhat Ballambattu; Nandeesha Hanumanthappa; Raveendranath Veeramani
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions.

Authors:  Mu Yang; Elena J Mahrt; Freeman Lewis; Gillian Foley; Thomas Portmann; Ricardo E Dolmetsch; Christine V Portfors; Jacqueline N Crawley
Journal:  Autism Res       Date:  2015-02-07       Impact factor: 5.216

Review 3.  Diagnostic Considerations in the Epilepsies-Testing Strategies, Test Type Advantages, and Limitations.

Authors:  Wei-Liang Chen; Heather C Mefford
Journal:  Neurotherapeutics       Date:  2021-09-16       Impact factor: 6.088

4.  [Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children].

Authors:  Chong-Yuan Lai; Rui-Hua Chen; Chun-Lan Zhong; Ming-Ming Ji; Bing-Fei Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 5.  Glutamatergic candidate genes in autism spectrum disorder: an overview.

Authors:  Andreas G Chiocchetti; Hanna S Bour; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2014-02-04       Impact factor: 3.575

6.  6q22.1 microdeletion and susceptibility to pediatric epilepsy.

Authors:  Przemyslaw Szafranski; Gretchen K Von Allmen; Brett H Graham; Angus A Wilfong; Sung-Hae L Kang; Jose A Ferreira; Sheila J Upton; John B Moeschler; Weimin Bi; Jill A Rosenfeld; Lisa G Shaffer; Sau Wai Cheung; Paweł Stankiewicz; Seema R Lalani
Journal:  Eur J Hum Genet       Date:  2014-05-14       Impact factor: 4.246

7.  Dissection of partial 21q monosomy in different phenotypes: clinical and molecular characterization of five cases and review of the literature.

Authors:  Edoardo Errichiello; Francesca Novara; Anna Cremante; Annapia Verri; Jessica Galli; Elisa Fazzi; Daniela Bellotti; Laura Losa; Mariangela Cisternino; Orsetta Zuffardi
Journal:  Mol Cytogenet       Date:  2016-02-24       Impact factor: 2.009

Review 8.  Genetic and epigenetic mechanisms of epilepsy: a review.

Authors:  Tian Chen; Mohan Giri; Zhenyi Xia; Yadu Nanda Subedi; Yan Li
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-13       Impact factor: 2.570

9.  16p11.2 microdeletion syndrome: a case report.

Authors:  D Dell'Edera; C Dilucca; A Allegretti; F Simone; M G Lupo; C Liccese; R Davanzo
Journal:  J Med Case Rep       Date:  2018-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.